loading
前日終値:
$1.95
開ける:
$1.89
24時間の取引高:
735.61K
Relative Volume:
1.14
時価総額:
$79.65M
収益:
-
当期純損益:
$-144.01M
株価収益率:
-0.5287
EPS:
-4.01
ネットキャッシュフロー:
$-113.02M
1週間 パフォーマンス:
-7.83%
1か月 パフォーマンス:
-23.19%
6か月 パフォーマンス:
-79.77%
1年 パフォーマンス:
-83.18%
1日の値動き範囲:
Value
$1.86
$2.13
1週間の範囲:
Value
$1.86
$2.29
52週間の値動き範囲:
Value
$1.86
$13.66

Biomea Fusion Inc Stock (BMEA) Company Profile

Name
名前
Biomea Fusion Inc
Name
セクター
Healthcare (1162)
Name
電話
(650) 980-9099
Name
住所
900 MIDDLEFIELD ROAD, REDWOOD CITY
Name
職員
106
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
BMEA's Discussions on Twitter

BMEA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BMEA
Biomea Fusion Inc
2.12 79.65M 0 -144.01M -113.02M -4.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-09 開始されました Edward Jones Buy
2024-09-27 アップグレード Rodman & Renshaw Neutral → Buy
2024-09-27 アップグレード Truist Hold → Buy
2024-08-29 開始されました CapitalOne Overweight
2024-06-11 ダウングレード Truist Buy → Hold
2024-06-07 ダウングレード Barclays Overweight → Equal Weight
2024-04-02 ダウングレード JP Morgan Overweight → Neutral
2024-02-06 開始されました Truist Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-06-26 ダウングレード Jefferies Buy → Hold
2023-05-12 開始されました Barclays Overweight
2023-03-29 繰り返されました Oppenheimer Outperform
2023-03-28 繰り返されました H.C. Wainwright Buy
2023-02-24 開始されました Citigroup Buy
2022-06-02 再開されました H.C. Wainwright Buy
2022-01-12 開始されました H.C. Wainwright Buy
2021-12-17 開始されました Oppenheimer Outperform
2021-05-11 開始されました JP Morgan Overweight
2021-05-11 開始されました Jefferies Buy
2021-05-11 開始されました Piper Sandler Overweight
すべてを表示

Biomea Fusion Inc (BMEA) 最新ニュース

pulisher
Apr 04, 2025

Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Reduces Earnings Estimates for Biomea Fusion - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

Barclays Issues Pessimistic Forecast for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

HC Wainwright Weighs in on Biomea Fusion Q1 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance

Apr 02, 2025
pulisher
Apr 01, 2025

Biomea Fusion’s Strategic Shift: A Year of Transformation - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Biomea Fusion Expands Team with Strategic Equity Compensation Package - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Biomea Fusion Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Biomea Fusion (NASDAQ:BMEA) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Biomea Fusion reports Q4 EPS (81c), consensus (93c) - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Biomea Fusion, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Breakthrough: Biomea's Diabetes Treatment Achieves Major Blood Sugar Control Milestone - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Virtu Financial LLC Makes New Investment in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Charles Schwab Investment Management Inc. - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Biomea Fusion (BMEA) to Release Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

BIOMEA FUSION Earnings Preview: Recent $BMEA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025
pulisher
Mar 28, 2025

Biomea Fusion Inc expected to post a loss of 92 cents a shareEarnings Preview - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of “Buy” by Brokerages - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Thomas Butler steps down as Biomea CEO - biocentury.com

Mar 26, 2025
pulisher
Mar 26, 2025

Biomea Fusion Appoints Michael Hitchcock Interim CEO - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Biomea Fusion appoints Mick Hitchcock to succeed Thomas Butler as interim CEO - Seeking Alpha

Mar 26, 2025
pulisher
Mar 25, 2025

Biomea Fusion’s SWOT analysis: stock’s potential amid clinical trials By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Biomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEO - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Biomea Fusion Announces Leadership Transition - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Former Gilead Sciences VP Named CEO as Biomea Advances Breakthrough Diabetes Drug - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

Strategy (MSTR) Executives Buy Company’s Preferred Stock - The Globe and Mail

Mar 25, 2025
pulisher
Mar 25, 2025

Stocks in play: Trilogy Metals Inc. - The Globe and Mail

Mar 25, 2025
pulisher
Mar 25, 2025

Biomea Fusion’s SWOT analysis: stock’s potential amid clinical trials - Investing.com India

Mar 25, 2025
pulisher
Mar 25, 2025

Biomea Fusion announces presentation of icovamenib preclinical, clinical data - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Biomea Fusion (NASDAQ:BMEA) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Biomea Fusion Presents Promising Clinical Data on Icovamenib at ATTD 2025, Highlighting Its Potential as a Disease-Modifying Therapy for Type 2 Diabetes - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Icovamenib Treatment in Patients with Severe - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose - Yahoo Finance

Mar 24, 2025
pulisher
Mar 23, 2025

Investors who Lost Money on Biomea Fusion, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationBMEA - ACCESS Newswire

Mar 23, 2025
pulisher
Mar 22, 2025

Biomea Fusion Insiders Recover Some Losses, Which Stand At US$91k - Yahoo

Mar 22, 2025
pulisher
Mar 21, 2025

D. Boral Capital Reiterates “Buy” Rating for Biomea Fusion (NASDAQ:BMEA) - Defense World

Mar 21, 2025
pulisher
Mar 11, 2025

Biomea Fusion stock hits 52-week low at $2.49 amid sharp decline - Investing.com

Mar 11, 2025
pulisher
Mar 09, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Biomea Fusion, Inc. (BMEA) - accessnewswire.com

Mar 09, 2025
pulisher
Mar 03, 2025

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Biomea Fusion reports inducement grant under Nasdaq listing rule - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

How Biomea Fusion's Latest Employee Stock Grant Reflects Its Talent Acquisition Strategy - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

An Investigation Has Commenced on Behalf of Biomea Fusion, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your BMEA Losses - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Mar 02, 2025

Biomea Fusion Inc (BMEA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):